Centiva Capital, LP Chemo Centryx, Inc. Transaction History

Centiva Capital, LP

  • $4.79 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$22.17 - $51.8 $1.12 Million - $2.61 Million
50,300 New
50,300 $2.6 Million
Q2 2021

Aug 16, 2021
SELL
$9.59 - $50.88 $109,767 - $582,372
-11,446 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$49.53 - $68.4 $566,920 - $782,906
11,446 New
11,446 $586,000
Q3 2020

Nov 16, 2020
SELL
$46.35 - $61.69 $659,560 - $877,848
-14,230 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$38.58 - $65.07 $548,993 - $925,946
14,230 New
14,230 $819,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email